Jason Eckel is a Nephrology physician affiliated with Waverly Hematology Oncology. OpenAlex indexes 9 publications with 326 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
790 SE Cary Pkwy
Suite 101
Cary, NC 275115678
Telephone
919-231-3966Provider last certified this registry record 11 Sept 2024.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka America Pharmaceutical, Inc.Program year202511 payments
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20254 payments
- Amgen Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
45.3%Loop diuretic8.9%Furosemide45%Torsemide38%Bumetanide18%Part D≥23 patientsAngiotensin receptor blocker (ARB)6.9%Losartan Potassium87%Valsartan13%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
17.8%SGLT2 inhibitor7.4%Farxiga66%Jardiance34%Part D≥18 patientsProton pump inhibitor4%Pantoprazole Sodium62%Omeprazole38%Part D<11 patients+ 6 more classes in this area
Nervous system
11.6%SSRI3.1%Trazodone Hcl77%Paroxetine Hcl23%Part D<11 patientsGabapentinoids2.5%Gabapentin100%Part D≥22 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel
American Journal of Nephrology
2022 - A Novel Missense Mutation of Wilms’ Tumor 1 Causes Autosomal Dominant FSGS
Journal of the American Society of Nephrology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”